Magnesium Sulphate for postoperative pain management

Intra-articular versus intravenous magnesium-sulphate as adjuvant to femoral nerve block for postoperative analgesia in arthroscopic anterior cruciate ligament reconstruction under general anesthesia: A Randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201503001053196

Enrollment

Registered

2015-03-03

Start date

2012-05-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Postoperative Pain

Interventions

Group P

Group IA

Group IV

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA physical status I and II aging from 18 to 60 years scheduled for arthroscopic ACL reconstruction

Exclusion criteria

Exclusion criteria: Patients with hepatic, renal, cardiac, hematological, or respiratory impairment, diabetic patients, morbidly obese, pregnant, patients with history of neuropathy, myopathy and neuromuscular diseases, patients with prior treatment with corticosteroids, calcium channel blockers, opioids patients with cognitive dysfunction that may interfere with the patient ability to provide reliable information about their postoperative pain

Design outcomes

Primary

Measure	Time frame
intensity of postoperative pain at rest as assessed by 0-10 visual analogue pain score (VAS).	—

Secondary

Measure	Time frame
Dynamic visual analogue pain score with movement (knee flexion).;The period of bearable pain;The total postoperative analgesic doses of diclofenac and the number of pethidine rescue doses;Side-effects;Serum magnesium levels	—

Countries

Egypt

Contacts

Public ContactSarah Abdel-Hakim

Assistant lecturer of anaesthesia, Cairo University

sarahamin_22@hotmail.com+201227476617

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026